8 news items
DEADLINE ALERT for ADSK, CMP, AKRO, EXAI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
ADSK
AKRO
CMP
17 Jun 24
of the foregoing, defendants had materially misrepresented the nature of the SYMMETRY trial, its usefulness in supporting any new drug application filed by Akero
DEADLINE ALERT for ADSK, CMP, AKRO, EXAI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
ADSK
AKRO
CMP
10 Jun 24
) that, as a result of the foregoing, defendants had materially misrepresented the nature of the SYMMETRY trial, its usefulness in supporting any new drug
DEADLINE ALERT for ADSK, CMP, AKRO, EXAI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
ADSK
AKRO
CMP
5 Jun 24
, defendants had materially misrepresented the nature of the SYMMETRY trial, its usefulness in supporting any new drug application filed by Akero
DEADLINE ALERT for ADSK, CMP, AKRO, EXAI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
ADSK
AKRO
CMP
29 May 24
) that, as a result of the foregoing, defendants had materially misrepresented the nature of the SYMMETRY trial, its usefulness in supporting any new drug application
DEADLINE ALERT for ADSK, CMP, AKRO, EXAI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
ADSK
AKRO
CMP
22 May 24
of the foregoing, defendants had materially misrepresented the nature of the SYMMETRY trial, its usefulness in supporting any new drug application filed
jsss70hk1ryzc1hj2ej75vyhugu8ykz9no2taah
ADSK
21 May 24
solution, and that's why we are excited to join a company that, at its core, supports the iterative nature of 3D and storytelling. We put a lot
kbn5 fclsc8utld9nipa0u9jejf25p6wx0qj7fue9
ADSK
AKRO
CMP
15 May 24
of the foregoing, defendants had materially misrepresented the nature of the SYMMETRY trial, its usefulness in supporting any new drug application filed
q79avdhzr3k82mnmdbqzdprrruwvbj1um1q2gy9 b08buh
ADSK
AKRO
CMP
8 May 24
of the foregoing, defendants had materially misrepresented the nature of the SYMMETRY trial, its usefulness in supporting any new drug application filed
- Prev
- 1
- Next